PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Khatri, Pooja
TI  - Patients with Mild Ischemic Stroke Benefit from IV-rtPA
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 14--14
VI  - 14
IP  - 6
4099  - http://mdc.sagepub.com/content/14/6/14.short
4100  - http://mdc.sagepub.com/content/14/6/14.full
AB  - There has been considerable debate regarding the use of intravenous recombinant tissue plasminogen activator (IV-rtPA) in patients with mild stroke symptoms. It has been unclear whether the potential benefits of improvement in neurologic outcomes outweigh the potential risks of hemorrhagic stroke, increased impairment, and death. This article presents results from a post hoc analysis of data from a subset of patients from the Third International Stroke Trial [IST-3; ISRCTN25765518], indicating that patients with mild stroke symptoms (ie, those having a National Institutes of Health Stroke Score of 0 to 5) may benefit from IV-rtPA.